06.12.2024 17:45:00
|
Syensqo announces the cancellation of repurchased shares
Syensqo announces the cancellation of repurchased shares
Brussels, Belgium – December 6, 2024 - 17:45 CET
In accordance with article 15 of the law of May 2, 2007 (transparency law) on the disclosure of important participating interests in issuers whose shares are admitted for trading on a regulated market, and following the cancellation of 658,488 own shares in December 2024 acquired in the framework of the first €50 million tranche of the ongoing €300 million Share Buyback Program, the updated information about the capital, the shares and the voting rights of Syensqo SA is as follows:
Total capital: EUR 1,351,624,292.82
New total number of shares and voting rights (= denominator): 105,217,929
The denominator serves as a basis for the notification of major holdings by shareholders. The thresholds, as provided by Article 11 of the Articles of Association of Syensqo SA, are therefore applicable.
As a reminder, the notifications of major shareholdings must be sent to the FSMA as well as to the Company.
Contacts
Investors & Analysts investor.relations@syensqo.com |
Media media.relations@syensqo.com | ||
Sherief Bakr Bisser Alexandrov Loïc Flament | +44 7920 575 989 +33 607 635 280 +32 478 69 74 20 | Perrine Marchal Laetitia Schreiber | +32 478 32 62 72 +32 487 74 38 07 |
Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
About Syensqo
Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates.
Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and health care applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.
Investor Relations sources
- Earnings materials
- Strategy
- Share information
- Credit information
- Separation documents
- Webcasts, podcasts and presentations
- 2023 Annual Integrated Report
- Subscribe to our distribution list
Attachment
Nachrichten zu Syensqo SA-NV
Jahresrückblick & Jahresausblick 2024/2025 – Wall Street Live mit Tim Schäfer
In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Vorweihnachtliche Zurückhaltung: SMI schlussendlich im Plus -- DAX geht schwächer aus dem HandelDer heimische Aktienmarkt schloss am Montag im Plus, wohingegen sich der deutsche Aktienmarkt abwärts bewegte.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |